Buy One Get One free -Llimited Time Offer X
Ikgdar Injection is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Other than this, Ikgdar Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Ikgdar Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Ikgdar Injection include Weakness. Apart from the aforementioned side effects, Ikgdar Injection can also lead to other problems, which have been listed below. Such side effects of Ikgdar Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Ikgdar Injection's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Ikgdar Injection's effects on the liver, heart and kidney are discussed below in the Ikgdar Injection related warnings section.
Ikgdar Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Hyperkalemia are examples of such conditions. Other conditions have been mentioned below in the Ikgdar Injection contraindications section.
Drug interactions for Ikgdar Injection have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Ikgdar Injection is not safe while driving, and is is not addictive in nature.
Ikgdar Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ikgdar Injection safe for pregnant women?
Ikgdar can have harmful effects in pregnant women. If you experience any discomfort after using Ikgdar, then discontinue the use and take your doctor's advice.
Is the use of Ikgdar Injection safe during breastfeeding?
Ikgdar may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Ikgdar Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Ikgdar. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ikgdar Injection on the Liver?
Ikgdar is not harmful for the liver.
What is the effect of Ikgdar Injection on the Heart?
There may be an adverse effect on the heart after taking Ikgdar. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Ikgdar Injection unless your doctor advises you to do so -
Is this Ikgdar Injection habit forming or addictive?
No, you will not get addicted to Ikgdar Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ikgdar Injection, you should not drive or work on any heavy machine, as Ikgdar Injection can make you drowsy.
Is it safe?
Ikgdar Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Ikgdar Injection is unable to treat or cure mental disorders.
Interaction between Food and Ikgdar Injection
Taking Ikgdar Injection with food is safe.
Interaction between Alcohol and Ikgdar Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ikgdar Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872